Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's accounts receivables for the quarter that ended in . 20 was TND0.00 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's accounts receivable are only considered to be worth 75% of book value:
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Accounts Receivable Related Terms
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Accounts Receivable Chart
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
Accounts Receivable
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
What does a Accounts Receivable of TND0.00 Mil mean?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) has a Accounts Receivable of TND0.00 Mil as of . 20. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Societe des Industries Pharmaceutiques de Tunisie-S I PHA T and its competitors.
Is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Accounts Receivable too high?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's current Accounts Receivable is TND0.00 Mil. Overall, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Accounts Receivable compare to BIEI and PTXTQ?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Accounts Receivable of TND0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Drug Manufacturers company?
A good Accounts Receivable depends on the Drug Manufacturers industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Societe des Industries Pharmaceutiques de Tunisie-S I PHA T and its competitors. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's current Accounts Receivable is TND0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T stock overvalued right now?
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) has a current Accounts Receivable of TND0.00 Mil. The current Accounts Receivable is TND0.00 Mil. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA), the current Accounts Receivable is TND0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.
12GF Score
Get the complete analysis for XTUN:SIPHA
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTUN:SIPHA has been successfully added to your 
